Literature DB >> 2895695

Rapid changes in plasma potassium during a game of squash.

A D Struthers1, C Quigley, M J Brown.   

Abstract

1. The game of squash has recently been associated with a high incidence of ventricular arrhythmias and sudden death. To investigate this further, plasma catecholamines and potassium (K+) were monitored during a game of squash in six normal volunteers. 2. No cardiac arrhythmias were seen in this study despite the subjects reaching maximum heart rates of 181 +/- 5 beats/min (mean +/- SEM). 3. During exercise, plasma K+ rose from 3.82 +/- 0.16 to 4.29 +/- 0.2 mmol/l, but after 90 s rest this fell to 3.68 +/- 0.28 mmol/l and after 180 s to 3.44 +/- 0.17 mmol/l. This rapid K+ shift could not be accounted for by generalized changes in venous acid-base status or by changes in venous plasma catecholamines. Although pretreatment with a beta 2-antagonist caused the overall plasma K+ levels to be higher, it had no significant effect on the fall in plasma K+ after exercise. 4. Such rapid K+ shifts after exercise might contribute to arrhythmogenesis in susceptible individuals. The precise mechanism of the fall in K+ after exercise remains undetermined, but it seems not to involve catecholamines stimulating beta 2-adrenoceptors and is more likely to be due to increased skeletal muscle blood flow and/or intracellular acidosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895695     DOI: 10.1042/cs0740397

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.

Authors:  N M Wheeldon; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Unexplained death in fit young people.

Authors:  J J Pandit
Journal:  BMJ       Date:  1992-10-03

3.  Beta 2 agonist/antagonist activity of salbutamol.

Authors:  R E Jonkers; R P Koopmans
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

4.  Salbutamol effects on systemic potassium dynamics during and following intense continuous and intermittent exercise.

Authors:  Muath M Altarawneh; Aaron Petersen; Robert Smith; David M Rouffet; Francois Billaut; Ben D Perry; Victoria L Wyckelsma; Antony Tobin; Michael J McKenna
Journal:  Eur J Appl Physiol       Date:  2016-10-22       Impact factor: 3.078

Review 5.  Interactive processes link the multiple symptoms of fatigue in sport competition.

Authors:  Axel J Knicker; Ian Renshaw; Anthony R H Oldham; Simeon P Cairns
Journal:  Sports Med       Date:  2011-04-01       Impact factor: 11.136

6.  Relationship between ventilation and arterial potassium concentration during incremental exercise and recovery.

Authors:  T Yoshida; M Chida; M Ichioka; K Makiguchi; J Eguchi; M Udo
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

7.  Acrolein inhalation alters arterial blood gases and triggers carotid body-mediated cardiovascular responses in hypertensive rats.

Authors:  Christina M Perez; Mehdi S Hazari; Allen D Ledbetter; Najwa Haykal-Coates; Alex P Carll; Wayne E Cascio; Darrell W Winsett; Daniel L Costa; Aimen K Farraj
Journal:  Inhal Toxicol       Date:  2015-01       Impact factor: 2.724

8.  Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.

Authors:  A Grove; L C McFarlane; B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

9.  Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol.

Authors:  N M Wheeldon; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

10.  Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.

Authors:  Jun Ma; Yan-Ping Bao; Ru-Jia Wang; Meng-Fan Su; Mo-Xuan Liu; Jin-Qiao Li; Louisa Degenhardt; Michael Farrell; Frederic C Blow; Mark Ilgen; Jie Shi; Lin Lu
Journal:  Mol Psychiatry       Date:  2018-06-22       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.